MedPath

CISPLATIN INJECTION, BP

CISPLATIN INJECTION, BP

Approved
DIN Number

02355183

Drug Class

Human

Market Date

Apr 10, 2012

Company
HC

Accord Healthcare Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02355183
AIG Number0113245002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA01 CISPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CISPLATINActive
Strength: 1 MG / ML
Monograph: CISPLATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.